The Beatson, West of Scotland Cancer Centre, Glasgow, UK.
Br J Haematol. 2010 Jun;149(5):675-92. doi: 10.1111/j.1365-2141.2010.08161.x. Epub 2010 Apr 16.
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Transplantation Society (BTS) has reviewed the available literature and made recommendations for the diagnosis and management of post-transplant lymphoproliferative disorder (PTLD) in adult recipients of solid organ transplants. This review details the risk factors predisposing to development, initial features and diagnosis. It is important that the risk of developing PTLD is considered when using post transplant immunosuppression and that the appropriate investigations are carried out when there are suspicions of the diagnosis. These must include tissue for histology and computed tomography scan to assess the extent of disease. These recommendations have been made primarily for adult patients, there have been some comments made with regard to paediatric practice.
英国血液学标准委员会(BCSH)血液肿瘤学分组和英国移植学会(BTS)共同成立的一个联合工作组,对现有文献进行了回顾,并针对实体器官移植受者移植后淋巴增殖性疾病(PTLD)的诊断和治疗提出了建议。本综述详细介绍了导致 PTLD 发生的危险因素、初始特征和诊断。在使用移植后免疫抑制时,需要考虑发生 PTLD 的风险,并且在怀疑诊断时应进行适当的检查。这些检查必须包括组织学和计算机断层扫描,以评估疾病的范围。这些建议主要针对成年患者,对于儿科实践也有一些相关的评论。